FAIRBANKS, Alaska, June 23, 2026 /PRNewswire/ - Contango Silver and Gold Inc. ("Contango" or the "Company") (NYSE:CTGO) (TSX:CTGO) is pleased to provide updates on its 2026 programs across the Contango Silver & Gold portfolio.Lucky Shot Surface Drill ProgramThe Lucky Shot surface drill program commenced on June 22, 2026 with the mobilization of two helicopter-supported drill rigs to site. A total of 29 holes across five drilling platforms—totaling approximately 6,800 meters—are planned (Figure 1). The program is designed to infill areas of known mineralization within the Coleman portion of the resource, while also executing step-out drilling to test the structural continuity between the Cole
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Contango Silver & Gold Provides Project Updates
- 82% of Group Travelers Will Pay a 'Peace Tax' to Avoid Money Arguments, CIT Bank Survey Finds
New research shows that financial preparation — not just good planning — is the key to enjoying group trips without the money stressRALEIGH, N.C., June 23, 2026 /PRNewswire/ -- More than half of U.S. adults (54%) have taken a group trip in the past five years with friends or family members not living in their household. While shared travel can be one of the most meaningful social experiences Americans make time for, a new survey from CIT Bank, conducted by Harris Poll in May 2026 among more than 2,000 U.S. adults, finds that financial preparation — or the lack of it — shapes whether those trips are remembered fondly or not. But
- Synchrony to Announce Second Quarter 2026 Financial Results on July 21, 2026
STAMFORD, Conn., June 23, 2026 /PRNewswire/ -- Synchrony (NYSE: SYF) plans to report its second quarter 2026 results on Tuesday, July 21, 2026. The earnings release and presentation materials are scheduled to be released and posted to the Investor Relations section of the Company's website, www.investors.synchrony.com, at approximately 6:00 a.m. Eastern Time. A conference call to discuss Synchrony's results will be held at 8:00 a.m. Eastern Time on that day; the live audio webcast and replay can be accessed through the same website under Events and Presentations. About SynchronySynchrony (NYSE: SYF) is a leading consumer finan
- Drive Group and Innoviz Sign Strategic Collaboration to Advance AI-Powered LiDAR Solutions for Security and Intelligent Transportation
The companies plan to integrate Innoviz LiDARs into Drive's Barak LightGuard system with the goal of achieving a sales target of $20 million by the end of 2027TEL AVIV, Israel, June 23, 2026 /PRNewswire/ -- Drive Group, comprising six leading transportation and infrastructure companies in Israel, and the technology company Innoviz Technologies Ltd. (NASDAQ:INVZ) ("Innoviz"), a leading supplier of high-performance, automotive-grade LiDAR sensor platforms, announced today the signing of a strategic collaboration agreement. The agreement is designed to promote the integration of Innoviz's existing LiDAR technology (InnovizSMART) into Drive Group's ITS (Intelligent Transportation Systems) and pe
- Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
Canada is the first country to approve a new botulinum neurotoxin serotype for aesthetic use Boey® is the first and only rapid-onset and short-duration botulinum neurotoxin serotype E approved for the temporary improvement in the appearance of glabellar linesBoey® offers a differentiated treatment option for many people who are curious about facial injectablesResults may be seen as early as eight hours after treatment and typically wear off within approximately two to three weeksBOTOX Cosmetic® (onabotulinumtoxinA) is the only neurotoxin clinically tested for use following treatment with Boey®IRVINE, Calif., June 23, 2026 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE:AB
- Takeda's Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Once-daily oral zasocitinib demonstrated statistical superiority over deucravacitinib for all primary and key secondary endpoints in plaque psoriasis studyMore than 35% of zasocitinib-treated patients achieved complete skin clearance (PASI 100) at week 16 – more than 2.5 times the response rate for deucravacitinibSafety profile was consistent with previous studies with no new safety signals identifiedTORONTO, June 23, 2026 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2
- MiniPay launches Visa debit card to connect stablecoin users in emerging markets to global spending
The digital Visa debit card connects MiniPay's millions of wallets to merchants in 46 countries, built on Gnosis Pay's infrastructure with no crypto knowledge required at the point of sale.OSLO, Norway, June 23, 2026 /PRNewswire/ -- MiniPay, Opera's self-custodial stablecoin wallet built on the Celo blockchain, today launched the MiniPay Card in collaboration with Visa and powered by Gnosis Pay. The digital Visa debit card enables eligible users in selected markets across Europe (EEA), Africa, Latin America and Southeast Asia to spend stablecoin balances at 175M+ merchant locations worldwide.
- Youlife Partners with Thingo Technology to Provide AI-powered Workforce Solutions Across China
SHANGHAI, June 23, 2026 /PRNewswire/ -- Youlife Group Inc. ("Youlife") (NASDAQ:YOUL), a leading blue-collar lifetime service provider in China, today announced that it had signed a strategic partnership agreement (the "Agreement" ) with Anhui Thingo Intelligent Technology Co., Ltd ("Thingo Technology"), a leading general AI agent platform company in China. Pursuant to the agreement, the two companies will collaborate across three key domains: AI Agent Business Development and Ecosystem Collaboration The partnership aims to evolve from simple workflow automation to intelligent decision-support systems capable of serving enterprises at scale, with specific focus on:Developing AI-powered soluti
- Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
MIAMI, June 23, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce a new partnership with Encore Optical Laboratory, a VSP-Accredited laboratory. Encore Laboratory will be supporting Innovative Eyewear with prescription fulfillment for online channels. The partnership is notable because of the expansive range of new lens technologies and finishing techniques that Encore is enablin
- Welltower Announces Date of Second Quarter 2026 Earnings Release, Conference Call and Webcast
TOLEDO, Ohio, June 23, 2026 /PRNewswire/ -- Welltower® Inc. (NYSE:WELL) today announced it will release second quarter 2026 financial results after the close of trading on the New York Stock Exchange on Monday, July 27, 2026. The Company will host a conference call and webcast on Tuesday, July 28, 2026, at 9:00 a.m. ET to discuss these results. The Company's earnings release will be available in the Investor Relations section of the Company's website. Investors and other interested parties may access the conference call in the following ways:At the Company's website: www.welltower.com.Via webcast: https://events.q4inc.com/atten
- Veea Inc. and TROLLEE Holdings Ltd. Extend Strategic Partnership to Deliver a Highly Advanced AI-Powered Autonomous Retail Ecosystem
NEW YORK and HONG KONG, June 23, 2026 (GLOBE NEWSWIRE) -- Veea Inc. ("Veea") (NASDAQ:VEEA), a first-to-market leader in edge-native hyperconverged networking and AI-powered cybersecurity, enabling distributed "micro AI factories," and TROLLEE Holdings Limited ("THL"), the global innovator behind the TROLLEE® smart shopping cart product line, today announced the extension of their a strategic partnership, initially commenced in 2018 and extended with a licensing agreement in May 2023 between Veea and a predecessor to THL, to accelerate the global smart retail revolution. This alliance represents the culmination of years of collaboration between the parties, resulting in a unified platform
- Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.
Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong ("Cloud Factory"). The two parties will jointly develop a specialized AI-driven ecosystem tailored for the beauty industry, leveraging cross-domain technological collaboration to transcend traditional growth limitations in the sector and usher in a new era of AI-powered, lean operations. The traditional offline beauty business model has long faced widespread op
- Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
Galectin has reached agreement with the FDA on the primary endpoint and regulatory path forward for the potential full approval of belapectinCompany intends to file the Phase 3 protocol in Q3 2026 and is actively exploring strategic and financial partnership opportunities to support the continued development and commercialization of belapectin NORCROSS, Ga., June 23, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), a biotechnology company focused on developing therapies for patients with advanced liver disease, today announced positive feedback from its recent in person Type C meeting with the U.S. Food and Drug Administration (FDA), supporting the advancement of belapec
- INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
MHRA minutes from May 12 pre-MAA Scientific Advice meeting confirm agreement across all questions covering CMC, non-clinical and clinical evidence packages MHRA pediatric feedback recognizes MissionEB Phase 2 data as demonstrating clinically meaningful symptomatic benefit, particularity pain and pruritis, and states the data could support positioning as chronic or intermittent supportive therapy for RDEB BOCA RATON, Fla, June 23, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has received official, accepted meeting minutes from its recent face-to-face pre-Marketing
- 64% of UK Consumers Want to Use Agentic AI for Shopping, According to New Research from Commerce and PayPal
LONDON, June 23, 2026 (GLOBE NEWSWIRE) -- Commerce (NASDAQ:CMRC), a data-centric provider of an open, AI-driven commerce ecosystem that enables businesses to unlock data, power intelligent discovery and deliver personalised experiences at scale, and PayPal today released new research revealing strong consumer interest in agentic shopping experiences alongside a clear demand for safeguards that keep consumers in control of purchases. The study, conducted by Logica Research, surveyed 1,000 online shoppers across the United Kingdom, as well as a further 2,000 across the US and Australia, to better understand consumer attitudes toward agentic shopping tools — AI-powered assistants that can re
- Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer
REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has begun treating patients in RASolute 305, a global, randomized Phase 3 clinical trial evaluating zoldonrasib in combination with standard of care chemotherapy as a first line treatment in patients with metastatic RAS G12D pancreatic ductal adenocarcinoma (PDAC). "Pancreatic cancer is a RAS-driven disease, and we recently reported that daraxonrasib, our RAS(ON) multi-selective inhibitor, significantly improved overall survival, progression-free survival, response rates, and prese
- Constellation and Walmart Announce Long-Term Agreement to Support Reliable, Emissions-Free Nuclear Energy in Illinois
Agreement supports Walmart’s expansion in the state and includes uprates at the Dresden Clean Energy Center Constellation (NASDAQ:CEG) and Walmart (NASDAQ:WMT) today announced a long-term nuclear power purchase agreement (PPA) for emissions-free electricity from Constellation’s Dresden Clean Energy Center in Illinois. The agreement includes approximately 176 MW of wholesale supply, including 30 MW of expanded generating capacity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260622721429/en/Constellation's Dresden Clean Energy Center located in Morris, Ill. Walmart will purchase energy, environmental attributes and capacity t
- RingCentral Expands AIR Pro to Deliver Agentic AI Capabilities Across Customer Engagement Portfolio
Native AI agents added to RingCX workflows giving businesses automated outreach, intelligent handoffs, and more RingCentral, Inc. (NYSE:RNG) today announced the expansion of AIR Pro™ to deliver agentic AI capabilities across the RingCentral customer engagement portfolio. The expansion includes new capabilities within RingCX™ that help businesses with end-to-end customer resolution, automated outreach, and intelligent hand-offs. These enhancements also strengthen how customer context is captured and carried within RingCX. When a conversation transfers to a live agent, that agent has a more complete picture, including prior interactions, data from connected systems via APIs, and relevant re
- Crawford & Company Appoints Regional Director for the Middle East and Strengthens UAE Team
Vic Noble, regional director, to retire at end of July 2026. Chris Wylie appointed as new regional director, Middle East Crawford & Company® (NYSE:CRD), a leading independent provider of claims management and outsourcing solutions, today announced the upcoming retirement of Vic Noble, regional director, Middle East, and a leadership transition in its Middle East operations, alongside new senior appointments in the United Arab Emirates. After a distinguished career spanning more than 45 years in the loss adjusting industry, Vic Noble will retire from Crawford at the end of July 2026. Noble joined Crawford in 2016 and has held numerous loss adjusting and leadership roles across the UK
- From the pitch to the airport: Cristiano Ronaldo and Vini Jr. chosen as Brazil’s dream travel buddies, reveals KAYAK
SAO PAULO, June 23, 2026 (GLOBE NEWSWIRE) -- KAYAK surveyed 2,000 travellers to find out which football player they'd most want to travel with, and where in Brazil they'd take them. Passport stamped for the Portuguese star Cristiano Ronaldo was chosen by 60% of respondents, followed by Vinícius Júnior (19%) and Endrick (9%). The reasons? 41% cited personal admiration, 23% want to see what goes on behind the scenes of an athlete's holiday, and 15% want to live a once in a lifetime experience alongside one of football's biggest names. The Northeast Steals the Show When asked where they'd take their football idol, 59% of Brazilians pointed to the Northeast region of the country, with dest